These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 9665400)

  • 1. Abnormal cornified cell envelope formation in mutilating palmoplantar keratoderma unrelated to epidermal differentiation complex.
    Akiyama M; Christiano AM; Yoneda K; Shimizu H
    J Invest Dermatol; 1998 Jul; 111(1):133-8. PubMed ID: 9665400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loricrin mutation in Vohwinkel's keratoderma is unique to the variant with ichthyosis.
    Korge BP; Ishida-Yamamoto A; Pünter C; Dopping-Hepenstal PJ; Iizuka H; Stephenson A; Eady RA; Munro CS
    J Invest Dermatol; 1997 Oct; 109(4):604-10. PubMed ID: 9326398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel insertional mutation in loricrin in Vohwinkel's Keratoderma.
    Armstrong DK; McKenna KE; Hughes AE
    J Invest Dermatol; 1998 Oct; 111(4):702-4. PubMed ID: 9764857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loricrin keratoderma: a novel disease entity characterized by nuclear accumulation of mutant loricrin.
    Ishida-Yamamoto A
    J Dermatol Sci; 2003 Feb; 31(1):3-8. PubMed ID: 12615358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A molecular defect in loricrin, the major component of the cornified cell envelope, underlies Vohwinkel's syndrome.
    Maestrini E; Monaco AP; McGrath JA; Ishida-Yamamoto A; Camisa C; Hovnanian A; Weeks DE; Lathrop M; Uitto J; Christiano AM
    Nat Genet; 1996 May; 13(1):70-7. PubMed ID: 8673107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loricrin gene mutation in a Japanese patient of Vohwinkel's syndrome.
    Takahashi H; Ishida-Yamamoto A; Kishi A; Ohara K; Iizuka H
    J Dermatol Sci; 1999 Jan; 19(1):44-7. PubMed ID: 9890374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and functional consequences of loricrin mutations in human loricrin keratoderma (Vohwinkel syndrome with ichthyosis).
    Schmuth M; Fluhr JW; Crumrine DC; Uchida Y; Hachem JP; Behne M; Moskowitz DG; Christiano AM; Feingold KR; Elias PM
    J Invest Dermatol; 2004 Apr; 122(4):909-22. PubMed ID: 15102081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Olmsted syndrome with squamous cell carcinoma of extremities and adenocarcinoma of the lung: failure to detect loricrin gene mutation.
    Ogawa F; Udono M; Murota H; Shimizu K; Takahashi H; Ishida-Yamamoto A; Iizuka H; Katayama I
    Eur J Dermatol; 2003; 13(6):524-8. PubMed ID: 14721769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variant of Vohwinkel's syndrome.
    Ali MM; Upadya GM
    Indian J Dermatol Venereol Leprol; 2006; 72(6):449-51. PubMed ID: 17179623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel c.545-546insG mutation in the loricrin gene correlates with a heterogeneous phenotype of loricrin keratoderma.
    Song S; Shen C; Song G; Mao X; Yan G; Wang X; Yan M; Zhong N
    Br J Dermatol; 2008 Sep; 159(3):714-9. PubMed ID: 18844868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Towards characterization of palmoplantar keratoderma caused by gain-of-function mutation in loricrin: analysis of a family and review of the literature.
    Gedicke MM; Traupe H; Fischer B; Tinschert S; Hennies HC
    Br J Dermatol; 2006 Jan; 154(1):167-71. PubMed ID: 16403113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutant loricrin is not crosslinked into the cornified cell envelope but is translocated into the nucleus in loricrin keratoderma.
    Ishida-Yamamoto A; Kato H; Kiyama H; Armstrong DK; Munro CS; Eady RA; Nakamura S; Kinouchi M; Takahashi H; Iizuka H
    J Invest Dermatol; 2000 Dec; 115(6):1088-94. PubMed ID: 11121146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Collodion baby and loricrin keratoderma: a case report and mutation analysis.
    Yeh JM; Yang MH; Chao SC
    Clin Exp Dermatol; 2013 Mar; 38(2):147-50. PubMed ID: 22831754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How do keratinizing disorders and blistering disorders overlap?
    Hamada T; Tsuruta D; Fukuda S; Ishii N; Teye K; Numata S; Dainichi T; Karashima T; Ohata C; Furumura M; Hashimoto T
    Exp Dermatol; 2013 Feb; 22(2):83-7. PubMed ID: 23039137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Periderm cells form cornified cell envelope in their regression process during human epidermal development.
    Akiyama M; Smith LT; Yoneda K; Holbrook KA; Hohl D; Shimizu H
    J Invest Dermatol; 1999 Jun; 112(6):903-9. PubMed ID: 10383737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutilating palmoplantar keratoderma successfully treated with etretinate.
    Wereide K
    Acta Derm Venereol; 1984; 64(6):566-9. PubMed ID: 6084939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered distribution of keratinization markers in epidermolytic hyperkeratosis.
    Ishida-Yamamoto A; Iizuka H; Manabe M; O'Guin WM; Hohl D; Kartasova T; Kuroki T; Roop DR; Eady RA
    Arch Dermatol Res; 1995; 287(8):705-11. PubMed ID: 8554380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppressing AP1 factor signaling in the suprabasal epidermis produces a keratoderma phenotype.
    Rorke EA; Adhikary G; Young CA; Roop DR; Eckert RL
    J Invest Dermatol; 2015 Jan; 135(1):170-180. PubMed ID: 25050598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical epidermolytic palmoplantar keratoderma presentation associated with a mutation in the keratin 1 gene.
    Terron-Kwiatkowski A; Terrinoni A; Didona B; Melino G; Atherton DJ; Irvine AD; McLean WH
    Br J Dermatol; 2004 Jun; 150(6):1096-103. PubMed ID: 15214894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vohwinkel's syndrome in three generations.
    Solis RR; Diven DG; Trizna Z
    J Am Acad Dermatol; 2001 Feb; 44(2 Suppl):376-8. PubMed ID: 11174420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.